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Medical travel has expanded rapidly in recent years, resulting in new markets and
increased access to medical care. Whereas several studies investigated the motives of
individuals seeking healthcare abroad, the conventional analytical approach is limited
by substantial caveats. Classical techniques as found in the literature cannot provide
sufficient insight due to the nested nature of data generated. The application of adequate
analytical techniques, specifically multilevel modeling, is scarce to non-existent in the
context of medical travel. This study introduces the guidelines for application of multilevel
techniques in public health research by presenting an application of multilevel modeling
in analyzing the decision-making patterns of potential medical travelers. Benefits and
potential limitations are discussed.
Keywords: medical travel, public health, policy, multilevel model, hierarchical linear model, medical tourism, policy
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INTRODUCTION
In recent years there has been a global increase in international medical travel (Lunt and Carrera,
2010). To date, research on medical travel has been typically focused on patients traveling for
treatment unavailable or inaccessible in their home countries (Lunt andMannion, 2014). Although,
country- or region-specific studies are starting to emerge (Johnston et al., 2012; Noree et al., 2014)
little is known as to why potential patients travel to specific foreign locations to pursue medical
treatment. Given the clear rapid growth of medical travel, understanding which factors influence
patients’ decisions on a cross-cultural level will provide essential background for the development
of eﬀective global health access policies (GHAPs).
A small number of qualitative and quantitative studies have attempted to unravel why
individuals choose to travel for medical treatment. However, several shortcomings become evident
when reviewing previous work in the psychological and epidemiological literature. First, the
extended use of survey methods with a lack of psychometrically validated questionnaires. Second,
the primarily descriptive approaches when analyzing medical travel data, which inadequate
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properties for statistical inference and high-confidence
applications. Third, quantitative studies in the field applied
traditional statistical methods—as multiple linear regression,
that cannot take into account the complex relationship behind
the factors analyzed (Gallup Organization, 2007; Varkevisser
et al., 2007; Gill and Singh, 2011; Noree et al., 2014). To resolve
these issues, better analytic tools combined with access to
reliable, validated measurements are needed.
At present, knowledge of factors involved in patient choice
is highly dispersed and vaguely connected (Johnston et al.,
2012; Hanefeld et al., 2014). Although, available information
may oﬀer interesting insights, the findings of most studies
cannot be directly integrated, indicating a lack of a robust,
comprehensive, and validated model. To unravel the complex
decision-making process, psychological drivers and barriers that
precede medical travel need to be assessed beyond general
economic and availability factors.
Two approaches—revealed and stated preference—have been
used to study decision-making processes in economics. Stated
preference (SP) is based on the individual’s choice between
hypothetical scenarios while revealed preference (RP) uses real
observations of actual choices in order to infer individuals’
preferences. SP studies are based on measurement tools in
simulated conditions, where RP are based on observation of
individual’s choices in real-world setting. Studies suggest (Burge
et al., 2005) that stated preference in this context may be used as
a reasonable proxy for the measurement of revealed preference.
Each approach has its own strengths and limitations. Revealed
preference models may generate results with higher external
validity, but are limited to real-world choices, leading to
collinearity problems among choices and the need for a
high number of observations (Cherchi and Ortúzar, 2007). In
contrast, analyzing stated preferences allows researchers not
only to create hypothetical alternatives, but also to explicitly
examine how diﬀerent attributes of a given alternative influence
the participants’ choice, providing a robust and accepted
methodology to model choice behavior (Small et al., 2005).
Moreover, stated preference models have been widely used in the
public health literature and have shown converging results with
revealed preference models (Mark and Swait, 2004; Burge et al.,
2005; Ryan et al., 2008; Watson and Ryan, 2010).
For the purpose of analyzing stated preference, two main
methodologies have been developed: Conjoint Analysis (CA) and
Discrete Choice Modeling (DCM). While both frameworks are
highly related, in the past decades there has been an increasing
support for using DCM over CA as a statistical tool for the
analysis of decision-making (Louviere et al., 2010). DCM has also
been successfully applied to public health research (Ryan et al.,
2012). Detailed explanations of CA and DCM are not provided
here and can be found in Louviere et al. (2010) or Small et al.
(2005).
The present research design was developed to interpret data
such as that from a prototypical DCM experiment in the field,
the London Patient Choice Project (LPCP) by Burge et al. (2005).
The LPCP investigated the impact of the factors that influenced
the decision of choosing between a local and an alternative-
hypothetical hospital. The factors included were waiting time,
proximity, type of hospital, reputation, and the possibility of
follow-up procedures or checks-ups. The design of the study was
based on presenting hypothetical scenarios in a DCM design.
While LPCP served as an inspiration, several diﬀerences can be
noted between LPCP and the present study.
The LPCP required participants to choose between two
alternative hypothetical scenarios. However, for the purpose
of our study, a classical DCM methodology was not directly
followed. Instead a hybrid approach was developed by using
a psychometric framework focusing on participants’ decisions
when presented with a hypothetical scenario followed by further
inquiry about the motivation behind those decisions.
Moreover, the LPCP and other patient choice studies focused
solely on decision-making processes between local hospitals.
In contrast, our method encompasses a global approach to
the hypothetical scenarios. In particular, by using a country-
specific approach (e.g., real locations, rather than hypothetical
descriptions), specific country-related evidence can be obtaining,
being directly relevant to medical travel policy development. A
country-specific approach is obtained by including previously
determined countries as attributes in the choice sets. The criteria
for country selection can be found in the Medical Travel Data
Collection section.
Finally, the LPCP focused on a patient population, similar
to most of the literature in the field. The present study is the
first of its kind considering a non-patient population. As every
individual could be considered as a potential medical traveler, key
information regarding which factors drive the decision-making
processes could be eﬀectively derived from both populations.
While testing prospective choices has several drawbacks, the
value of having this knowledge is crucial when developing
evidence-based policies related to the implementation of large-
scale medical travel programs.
Based on previous findings and the specific research purposes,
a new approach to modeling decision-making process in medical
travel was developed. This approach examines factors that
influence the individuals’ decision to travel abroad for non-
urgent and essential medical purposes. Its core innovative
features include the development of a new medical travel
questionnaire based on country-specific hypothetical scenarios
(targeting a non-patient population) and the application of
a multilevel generalized linear model for analyzing the data
collected with the mentioned tool.
The objective of this article is to introduce the new
measurement and present the analysis method for medical
traveling data by clarifying the theoretical considerations behind
the choice of particular multilevel models and presenting results
from a case study to highlight its flexibility and usefulness.
Furthermore, it is intended to raise awareness of the need
for advanced statistical methods when analyzing complex
hierarchical structures commonly found in medical travel data
(e.g., data from individuals traveling to diﬀerent countries).
At the same time, the benefits and drawbacks of previous
strategies that have been selected for studying decision-making
processes underlying medical travel are discussed in comparison
to the proposed methodology. Careful use of the data collection
method and the statistical analysis could be of benefit not only
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to GHAP research, but also to other fields that use population
measures to support evidence-based policymaking.
MATERIALS AND METHODS
This study adapted the framework proposed by Louviere et al.
(2000) for conjoint experiment design. The present questionnaire
relied on a previously validated pathway for the design process
and involved the use of four steps as outlined below.
Step One: Defining Attributes
Specific Procedures
Two procedures, hip replacement and heart valve replacement,
that were considered as elective, very common, costly or relevant
enough to justify traveling were chosen as treatment parameters.
Hip and heart valve replacement were considered proxies for
invasiveness, with hip replacement being less dangerous or life-
threatening than heart valve replacement. Previous studies have
shown that patients’ decision-making is aﬀected by being in
need of a more invasive procedure. In particular, the influence
of interpersonal factors is greater when facing such a decision
compared to the need for a less invasive procedure (Victoor et al.,
2012).
Specific Countries
The countries included in the questionnaire (see Table 1) are
considered potential senders or receivers countries of foreign
patients, and play a crucial role in the actual medical travel
market. Moreover, they oﬀer a broad range of various healthcare
system characteristics. BRICS (Brazil, Russia, India, China, and
South Africa) countries have intentionally been excluded due
to their unique socioeconomic characteristics, which need to
be considered in the future and are currently being studied
individually in related work not discussed here.
Traveling abroad for medical reasons requires patients to
consider distance and inconveniences caused by physical travel.
TABLE 1 | Summary of attributes and their levels.
Countries Procedures Driving
factors
Demographic
measures
Australia Heart valve
replacement
Quality Previous medical
traveling experience
Dubai Hip replacement Cost Home country quality
Germany Waiting
list
Home country cost
Great Britain Home country waiting list
Malta Socioeconomic Status
New Zealand Income
Philippines Employment status
Portugal Gender
Qatar
Singapore
United States of
America
Thailand
These factors have been shown to moderate the decision of
traveling abroad for medical purposes (Burge et al., 2005;
Exworthy and Peckham, 2006). Studies have shown that distance
is a key factor, whereby patients (especially elderly patients),
prefer closer healthcare providers. Nonetheless, this distance
factor is dismissed if a method of easy access is available (by
private or public transportation), if the individual is already
willing to travel or if that person is highly educated (Victoor
et al., 2012). Finally, the eﬀect of distance could be also dismissed
or foster depending upon the type of medical procedure under
consideration (Damman et al., 2011). Therefore, distance is a
highly influential factor on patient’s decisions, as indicated in the
literature, but is moderated by several second order factors.
Specific Driving Factors
Patients are more likely to travel abroad for medical purposes
if the healthcare system in their home country is perceived as
low quality, if the healthcare associated costs are considered
unacceptable, or waiting times are too long (Burge et al., 2005;
Jotikasthira, 2010; Gill and Singh, 2011). Moreover, the quality
of the healthcare system has been found to be one of the
most prominent indicators in the decision-making process when
related to the destination country. Patients also highly value the
availability of state-of-the-art technology (Horowitz et al., 2007).
When evaluating alternative destinations, medical travelers
reject destinations that they perceive as providing inadequate
care quality (Marlowe and Sullivan, 2007). However, people
are willing to make a trade-oﬀ between the quality of the
hospital and potential savings, leading to the choice of a lower
quality hospital, if there is potential to save money, under
certain circumstances (Jotikasthira, 2010). For instance, medical
travelers from industrialized countries including Europe and
North America (Gill and Singh, 2011) seek healthcare in less
industrialized countries driven by the lower costs (Horowitz
et al., 2007). Medical travelers thus consider financial savings as
an important factor but only when there is also an acceptable
quality standard of medical care (Jotikasthira, 2010).
Shorter waiting lists are also an important factor for
individuals when considering going abroad for medical purposes,
but only after considering the healthcare system’s quality (Burge
et al., 2005). Previous research provides evidence relative to
how patients’ motivation to travel for medical care is boosted if
waiting time for medical travel can be reduced (Ryan and Gerard,
2003; Burge et al., 2005). The importance given to this potential
reduction of the waiting list however depends on the medical
condition of the patient (Ricketts et al., 2004; Exworthy and
Peckham, 2006) and on the proximity of the new provider (Burge
et al., 2005). Nevertheless, waiting list has also been consistently
listed as a relevant factor in the existing literature (Burge et al.,
2005; Jotikasthira, 2010; Johnston et al., 2012).
Individuals are generally most willing to travel for access
to higher-quality treatment, followed by potential savings and
the avoidance of long waiting lists (Burge et al., 2005; Gallup
Organization, 2007; Keckley and Underwood, 2008; Jotikasthira,
2010). As argued by Exworthy and Peckham (2006), this may
be due to a search for convenience, and thus understanding of
the interaction of these variables along with trade-oﬀs is very
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important. Important trade-oﬀs are made between these specific
factors and the home country’s healthcare features. As a result,
satisfaction with the perceived quality, cost, and waiting time of
the home country’s healthcare are assessed in order to obtain
information relative to these trades-oﬀs.
Demographic Questions
In addition to the promise of better quality, reduced costs and
shorter waiting lists certain demographic characteristics are also
known to play an important role in the decision to travel for
medical care.
Employment status, income, and occupation are considered
to be proxy measurements of socioeconomic status (SES)
(American Psychological Association, Task Force on
Socioeconomic Status, 2007). Highly educated patients and
patients with higher income (Burge et al., 2005; Exworthy and
Peckham, 2006) make an active choice of health care provider
compared to patients without those characteristics (Victoor et al.,
2012). Individuals with higher educational level (Exworthy and
Peckham, 2006; Lako and Rosenau, 2009) are also more likely to
travel abroad for medical purposes.
Previous medical travel experiences (Varkevisser et al., 2007;
Victoor et al., 2012) are also an important moderator of patients’
decisions, where individuals tend to rely on their previous
experience as the most important information source (Kolstad
and Chernew, 2009; Lux et al., 2011).
Step Two: Creating Scenarios
The chosen attributes were combinations of one of two
procedures, one of three driving factors, and one of 12 destination
countries. An example scenario would be:
“Imagine your doctor says you require heart valve replacement, yet
the waiting list is long in your home country. However, in Malta,
the waiting list is considerably shorter. Under these circumstances,
would you consider traveling to Malta for this procedure?”
Attempting to simulate the real medical decision-making process
as much as possible, the logic behind the scenario’ structure is:
1. Patient receives the information about his medical condition
and the necessity of a medical procedure.
2. Patient seeks information related to the conditions of the
medical procedure in his home country.
3. Patient considers alternative countries that provide a better
situation for that medical procedure.
Presenting the participant with a real-world based situation
creates the possibility to capture generalizable trade-oﬀs between
factors, simulating realistic patient’s decision making processes.
Step Three: Determining Scenario Sets
CA/DCM studies use factorial or fractional factorial designs,
as they need to present two scenarios with a diﬀerent set of
characteristics at the same time for analyzing the diﬀerential
factors behind the decision making processes. This results in
an unmanageable number of possible combinations between
scenarios and attributes (Louviere et al., 2000). In contrast,
the proposed medical travel questionnaire is based on the
presentation of only one scenario at a time, allowing a complete
randomization of the possible 72 scenarios across participants,
generating balanced conditions for each attribute.
The medical travel questionnaire was designed as an on-
line questionnaire, prepared to be adapted to the contingencies
associated by the data collection in social media. Qualtrics
software was used for the generation of blocks randomly
assigned to participants, once the country of origin was
taken into consideration. Participants did not receive items
assessing their home country, as home country was not fully
randomized between participants. A country was therefore
randomly assigned—only controlling for home country to be
excluded—and remained constant across the combination of
procedure and reasons, so that participants answered more than
one item for a given country.
Block randomization involved developing blocks of six
questions to ensure that all participants encounter all possible
combinations between factors and procedures within a randomly
given country. For each driving factor (quality, cost, and waiting
list), two questions regarding the two procedures (hip or heart
valve replacement) were generated. All the questions in each
given scenario are explicitly referred to one country.
The decision to include only six scenarios can be justified
by several means. Firstly, measurement fatigue leading to
withdrawal was considered a legitimate concern if participants
were presented with the all possible (72) scenarios. Furthermore,
it is not necessary for patterns to emerge if the large sample is
suﬃciently large, which would make for even more insightful
results if participants are unlikely to recognize that each scenario
is entirely unique and not simply a collection of all possible
permutations.
Therefore, the trade-oﬀ between a large inventory of responses
per participant and a large sample of participants answering
fewer items is a significant decision but may bemodified in future
versions if resources or samples are available to complete the
entire questionnaire. Given the nature of the data and current
purpose of this approach, it is considered preferable to have
a large number of participants answering a smaller number of
items.
Step Four: Estimating Model Parameters
Why Should Multilevel Models Be Applied in Medical
Travel Research?
Traditional statistical methods such as multiple linear regression
have dominated quantitative research in medical travel. They
provide valuable information regarding the diﬀerent factors
involved in medical travel, but these are limited to local settings
and often hold unrealistic assumptions about the data analyzed.
Medical travel is an international phenomenon that can be
structured in diﬀerent layers and levels of action. Fittingly,
multilevel models are the proper analytical tool for taking into
consideration these classes of structures, providing information
regarding all the units involved. No traditional technique would
therefore be adequate when analyzing medical travel data.
Classical statistical tools assume that all variables are
constrained in one level of analysis, where all the predictors
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are hypothesized to be characteristics within the same level of
analysis (Snijders and Bosker, 2012). However, this is not the case
when studying the influence of the country of destination in the
decision-making processes for medical travel. Due to advances in
modeling approaches, the assumption of independence between
observations is no longer a valid axiom in statistical analysis,
as demonstrated by the increasing number of studies that use
multilevel methods for analyzing the interdependencies among
observations.
Here, multilevel methods are defined as the set of techniques
that allow the estimation of parameters in diﬀerent levels of
the data in order to take into account the nested structure
of the observations in a given dataset. The flexibility of
the multilevel method is achieved by defining hierarchical
structures where higher-level units capture the dependency
among units in the lower level. Therefore, instead of assuming
independency between observations, the researcher can explore
those relationships by the inclusion of higher-level units,
enhancing the quality of the information given by the model
by providing an explicit explanation of first level units’ shared
variance.
Although, several names can be found in the literature for
referring to these models (such as hierarchical linear models a
random-eﬀects models) here we will refer to them as multilevel
methods (MLM). One of the main theoretical advantages of
MLM is its ability to capture the country-specific eﬀects arising
from diﬀerences in regional characteristics that modulate the
individual’s response in a decision-making processes. At the same
time, MLM relies on less strict assumptions than conventional
DCM models and does not require non-independence among
observations, hence providing a solution to the multicollinearity
problem that is so common to questionnaire-based datasets.
Snijders and Bosker (2012) recommended the use of the
intraclass correlation coeﬃcient (ICC) for examining the amount
of variance explained by second level units in a model, where
values ranging from 0.05 to 0.2 are common in cross-sectional
social science research (Peugh, 2010).
Failing to take into account these interdependencies leads
to underestimation of the standard deviation of the regresssion
coeﬃcients and dramatic increase of Type 1 error (Austin et al.,
2003). As the ICC grows, standard deviation and parameter
estimations tend to be inaccurate (Julian, 2001), generating
potentially incorrect predictions and misleading conclusions.
In addition, it is mandatory to take into consideration the
higher-level units (e.g., countries) when disclosing medical
travel patterns and processes. Conclusions drawn from
classical techniques are based on biased estimation of the
defined parameters (and incorrect standard error estimations),
potentially leading researchers to draw misinformed conclusions
and misguided recommendations for practitioners. Multilevel
methods provide the solution for adjusting parameter estimation
to the hierarchical nature of the data by modeling the existent
interdependencies.
As country-specific scenarios were generated, a hierarchical
model where country of destination was the second-level variable
could be easily derived. Multilevel logistic models allow the
study of the non-independent relationships between destination
country and a set of fixed eﬀects while placing the focus on
these country-related random eﬀects. Furthermore, country-
specific information can be obtained when using these methods,
simultaneously clarifying the complicated interactions between
factors in the decision-making processes. This information is not
only richer, but also more accurate than that obtained by using
traditional methods, allowing the estimation of fixed and random
eﬀects along with their standard errors (Snijders and Bosker,
2012).
An exhaustive review of multilevel methods is beyond the
scope of this article, and important features of multilevel logistic
methods are omitted here. Interested readers may refer to
the following literature (Pinheiro and Bates, 2000; Hox, 2002;
Raudenbush and Bryk, 2002; Gelman and Hill, 2007).
Previous empirical evidence generated by multilevel models
in medical travel has not been found using DCM/CA paradigms,
but multilevel logistic methods have been widely used in other
areas of public health research (Rice and Leyland, 1996; Duncan
et al., 1998). Moreover, the eﬀect of country as a second-level
unit has been specifically analyzed (Stegmueller, 2013) and robust
evidence exists to justify its use in this analytical method. The
multilevel approach presented here is the first application of
multilevel methodology to medical travel data.
Mathematical Definition of the Multilevel Model
The model under consideration is a two-level random intercept
model. The individual’s response i (i = 1,. . . , nj) for a country j
(j = 1, . . . , J) is modeled (γij)as follows:
γij = ln
πij
1 − πij
= β0 + β1x1j + β2 x2j + . . . + βkxkj + u0j + eij
u0j∼N(0,"u) :"u= [σ2j ]
eij∼N(0,"e) :"e= [σ2e ]
cov
(
u0j, eij
)
= 0
The individual’s decision to travel is assumed to be binomially
distributed, where the logit of the probability of traveling (πij)
abroad depends on a linear combination of the model intercept
(β0), a set of k individual-level predictor variables xij—with their
βi coeﬃcients—the random error term at individual level (eij)
plus the random error term at context level (u0j). Both error
terms are assumed to be normally, identically u0j ∼ N (0,"u) :
"u =
[
σ
2
j
]
; eij ∼ N (0,"e) : "e =
[
σ2e
]
; and independently
distributed (cov
(
u0j, eij
)
= 0). The distributions are defined
as diagonal matrices with variance components in the diagonal
elements and with zeros in the oﬀ-diagonal elements.
Individual-level variance is fixed as σ2e =
π2
3 , as recommended
by Goldstein et al. (2002) or Rasbash et al. (2009). The model
is expressed in terms of the mean or expected value of γij
for an individual i in a group j with a value xij. Individual
terms predictors include the studied procedure, driving factors
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(e.g., how the individual decision changes when considering two
diﬀerent procedures) and sociodemographic features described
in the previous section, plus relevant interactions among the
variables at this level (e.g., if the influence of the considered
procedure varies when considering potential savings, the quality
or the waiting time for that specific operation).
A two-level random intercept model is sensitive to diﬀerences
across country-level units, while concurrently holding all the
eﬀects constant across countries (Gelman and Hill, 2007), as
random eﬀects are only modeled regarding the error terms.
Therefore, the eﬀect of the included individual level variables is
modeled as fixed for each given country. This model provides
valuable information while representing the simplest model that
could be derived. In order to generate evidence of the existence
of country-specific trends in medical traveling previous to extent
this methodology. Further developments could include random
slopes models andmore complex variance models (Rasbash et al.,
2009), or alternatively revert to universal scenarios for parallels
and predictors of pragmatic designs.
Although the random-intercept model is considered to be the
most parsimonious of its class, it provides valuable information
regarding the usefulness of the hierarchical linear model given
the context. Firstly, a random-intercept model is the basis for
demonstrating the necessity of multilevel models in a given data
prior to the application of more complex multilevel models.
Secondly, information about both, fixed and random eﬀects
could be obtained with an unbiased parameter estimation. The
parameter estimates (and the corresponding estimation error)
contain the relevant information for explaining the diﬀerent
trade-oﬀs between the reasons, procedures and countries of
destination, and how each of them are related to the decision
of going abroad for medical care. Consequently, this model is
expected to oﬀer richer information than classical techniques
for both, fixed and random eﬀects defined therein. Multilevel
logistic models allow not only parameter estimation for fixed
and random eﬀects, but also for cross-level eﬀects, which is an
important improvement over traditional multivariate analysis.
The specific eﬀect of driving factors (e.g., the impact of the cost of
the procedure on the decision making process) or even the eﬀects
of second level units characteristics (e.g., geographical location of
the country) can be estimated along with interactions between
countries’ and the driving factors or procedures They are not
included in the previous formulation of the model for the sake
of simplicity, but could be easily be incorporated to the model if
needed, following the references previously provided.
CASE STUDY: APPLICATION TO MEDICAL
TRAVEL DATA
Introduction to Zhukovsky et al. (2015)
Medical Travel Data
Following the aforementioned approach, the proposed
framework for collecting and analyzing medical travel was
applied. An illustration of the methodology is provided in order
to ease the comprehension of the previous theoretical approach,
and to encourage researchers to confront the results thereupon
presented with the evidence provided by alternative methods.
Hence, both data and results presented hereafter are intended
to be considered only as an example of the possibilities and
flexibility of the presented method.
The method was illustrated by using data presented in
Zhukovsky et al. (2015), and readers interested in further
details on the dataset are referred to contact the authors of
the paper. The data was collected under the auspice of the
Global Health Access Project, developed by the Junior Researcher
Programme, in May and August 2014. An online questionnaire
was developed following the specifications abovementioned on
this article. This dataset consisted of 3174 observations obtained
from 529 participants, where the main characteristics of the
sample can be found in Table 2. Only complete observations
were included in the model, following the analysis decisions
originally made by the authors in Zhukovsky et al. (2015). The
decision to travel abroad (individual’s response to undergo for
medical care to a given country) diﬀered across various attribute
categories (Table 3), where procedure, reason and countries of
TABLE 2 | Characteristics of study sample.
Variable Value Freq. % Mean (SD)
GENDER
Female 67.8
Age 27.6 (10.36)
MEDICAL TRAVEL EXPERIENCE
Yes 5.0
No 95.0
REGION OF ORIGIN
Europe* 87.7
Other 12.3
EDUCATION
Master Degree, PhD or eq. 43.6
Bachelor Degree or eq. 30.9
Secondary School 19.0
Higher Vocational Training 6.5
INCOME
Very high 1.7
Above average 22.1
Average 43.5
Low 29.8
Below poverty 2.9
TIME ABROAD
No time abroad 62.1
Between 6 months and 1 year 14.5
More than a year 23.3
RATING OF LOCAL HEALTHCARE**
Quality 3.7 (0.98)
Waiting 2.7 (1.13)
Cost** 3.5 (1.11)
*Europe = Germany, Slovenia, UK, Spain, and other countries **Values refer to a Likert
scale ranging from one to five, with 1 = very negative, 2 = negative 3 = neutral, 4 =
positive, 5 = very positive.
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TABLE 3 | Frequency of agree to travel abroad due to medical purposes.
Condition Value Percentage of agreement to travel (%)
OVERALL
Would agree to travel 66.9
BY PROCEDURE
Hip Replacement 64.0
Heart Valve 69.8
BY REASON
Quality 82.0
Waiting Time 63.5
Cost 55.4
BY COUNTRY
Australia 72.8
Dubai 66.0
Germany 91.6
Great Britain 89.1
Malta 70.0
New Zealand 73.7
Philippines 41.1
Portugal 68.0
Qatar 57.8
Singapore 56.7
United States of America 74.0
Thailand 42.5
destination were identified as the most influential factors both
from a theoretical and statistical point of view. As indicated by
Zhukovsky et al. (2015), an interaction between procedure and
reason was observed and was included in the multilevel model
presented here.
Descriptive results (Table 3) show that individuals generally
agree to travel for medical care, but the conditions surrounding
that decision could play an important role for the final decision.
Each individual responded to six questions that consisted of
all six possible combinations of three procedures and two
reasons and each of the six questions featured randomly assigned
countries of destination. This design invites a hierarchical
model where responses are nested within country. Therefore,
the demographic variables, procedure, and reason are included
in the model as first level variables (e.g., they are defined as
fixed eﬀects), nested in the country of destination (second level
procedures, defined as random terms). Moreover, in order to
illustrate the abovementioned approach, the consequent analysis
will be restricted to be a random-intercept model with country of
destination as the unique random term.
Random Intercept Model
Four multilevel models were included in the results. First,
the null or unconditional model was created, including only
the intercept and the random term (country of destination).
Second, the unconditional model was expanded by including
the main interest eﬀects (procedure and reason). Thirdly, the
interaction between the main eﬀects was included, as it has been
previously shown to play an important role in this analysis.
Lastly, demographic variables described in Table 2were included
in the model as first level covariates to serve as control variables
for the analysis of the main eﬀects. Moreover, an additional
single-level model was included for comparison purposes. This
model includes all the fixed eﬀects from the final model without
the random term.
The reference categories were identified as follows: for
procedure, the less invasive procedure (i.e., hip replacement)
was selected as the reference category. For reason, cost was the
reference category, as it was the most balanced procedure in
terms of agreement and disagreement with traveling abroad for
medical purposes. Female gender was the reference category for
the named variable. Income and education were centered on
their mode category (Income = Average income; Education =
Master’s degree, PhD, or equivalent). Three variables related to
the evaluation of the home country’s healthcare system were
centered on their mean values. Any other variable was fixed to the
categories that represented the absence of the referred variable
(e.g., for “Previous Medical Travel Experience” the reference
category was “No”).
All the models were estimated using restricted maximum
likelihood with Gaussian-Hermite quadrature integration (10
integration points). ICC measures were provided in order
to evaluate the percentage of variance due to the random
eﬀect. In order to evaluate the appropriateness of the specified
models, AIC, BIC, and likelihood tests are used. R software (R
Development Core Team, 2015) and lme4 package (Bates et al.,
2015) were chosen as the software platform for performing the
analysis.
Case Study Results
Parameter estimations for the fixed and random eﬀects, as well as
ICC, AIC, BIC, and likelihood ratio are presented in Table 4.
Since adding interactive eﬀects of procedure and reason and
demographic eﬀects improved the model fit, only the final model
was interpreted. Firstly, ICC results shows that almost 20%
variance in the first level units is accounted by the eﬀect of the
country of destination, demonstrating the necessity of taking
this hierarchical structure into consideration for performing
unbiased parameter estimation. Similarly, both AIC and BIC
were decreasing within the nested models, and likelihood-ratio
test is highly significant when comparing this model with amodel
without the fixed term demographic eﬀects. Therefore, all the
indicators reflect the adequacy of both the random intercept
model and the model including the fixed term covariates for our
data.
Results show that decisions to go abroad for medical purposes
were influenced by several factors, and that those relationships
were complex, with several factors interacting with each other.
Firstly, the odds of going abroad if a higher quality of the
treatment was expected was 3.93 times the odds of agreeing to
medical travel when considering the eﬀect of the procedure’s cost.
Quality seems to be the most compelling factor when deciding to
go abroad for medical traveling or not.
Moreover, an interactive eﬀect between the procedure and the
reason was found. When the procedure under consideration was
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TABLE 4 | Fixed effect estimates (top) and random effect estimates (bottom) for models of the predictors of agreeing to travel.
Parametersa Null model Main effects Main effects and
interaction
Final model Single-level model
FIXED EFFECTS
Level 1
Intercept 2.24 (1.26)** 1.12 (1.27) 1.33 (1.29) 4.71 (1.62) 5.73 (1.49)**
Procedure
Heart valve replacement 1.36 (1.08)** 0.97 (1.14) 1.00 (1.15) 0.98 (1.14)
Reason
Waiting List 1.46 (1.09)** 1.01 (1.14) 0.99 (1.15) 1.00 (1.14)
Quality 4.26 (1.1)** 3.76 (1.16)** 3.93 (1.15)** 3.52 (1.16)**
Procedure × Reason
Heart valve replacement × Waiting list 2.19 (1.21)** 2.13 (1.22)** 2.17 (1.21)**
Heart valve replacement × Quality 1.27 (1.24) 1.31 (1.25) 1.27 (1.23)
Income
Below Poverty 0.64 (1.36) 0.49 (1.34)*
Low 0.84 (1.18) 0.75 (1.17)
Above Average 0.67 (1.20)* 0.80 (1.19)
Very High 0.30 (1.48)** 0.37 (1.45)**
Time Abroad
Between 6 months and 1 year 3.57 (1.19)** 3.17 (1.17) **
More than a year 7.18 (1.25)** 6.64 (1.23) **
Rating of local healthcare
Waiting list 0.75 (1.10)* 0.75 (1.09)**
Cost 1.30 (1.09)* 1.19 (1.08) *
Quality 64 (1.10)** 0.6 (1.10)**
Education
Secondary School 1.73 (1.21) ** 1.4 (1.20)
Vocational School 1.25 (1.22) 1.05 (1.21)
Bachelor Degree or eq. 0.44 (1.21) ** 0.45 (1.19) **
Previous medical travel
Experience in medical travel 0.61 (1.28)* 0.59 (1.26) *
Gender
Male 0.82 (1.17) 0.8 (1.16)
RANDOM EFFECTS
Level 2 (Country of destination)
Intercept 1.80 (2.16) 1.93 (2.24) 1.94 (2.24) 1.99 (2.29) –
Model summary
ICC – 16.70% 16.77% 21.07% –
Deviance statistic 3774 3488.1** 3470** 3294.8** 3590.1**
AIC 3708 3498.1 3527.1 3336.8 3630.1
BIC 3720.8 3528.4 3484.8 3463.9 3751.2
aAll the results are presented as odd ratios with standard errors in parentheses *Significant at 0.05 level. **Significant at 0.01 level.
heart valve replacement, the odds ratio between going abroad
for this procedure was 2.13 times greater when considering
shorter waiting time than when pondering costs. This eﬀect was
not found to be significant when the odds ratio were referring
to the diﬀerence between the odds of deciding to go abroad
for medical care between heart valve and hip replacement for
quality and cost. Hence, it was observed that when individuals
are faced with a highly invasive procedure (e.g., heart valve
replacement), the associated time pressure is a highly relevant
factor. However, when the procedure is less risky and less life
threatening, the monetary cost become as important as waiting
time. The interactive eﬀect of waiting time or cost conditional
upon the procedure was less important the main eﬀect of quality,
which is highlighted as the most influential of all the reasons
analyzed here.
Demographic variables provide important information for
creating profiles of medical travelers. Firstly, gender was not an
influential variable in the decision-making process. Secondly,
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TABLE 5 | Percentage, estimated odd ratios, and estimated probability of
participants willing to travel for care for each country.
Country Sample agreement
to travel (%)
Estimated odds
ratios for travel
Estimated probability
of travel (%)
Australia 72.8 1.28 56.1
Dubai 66.0 0.86 46.4
Germany 91.6 4.19 80.7
Great Britain 89.1 3.65 78.5
Malta 70.0 1.01 50.3
New Zealand 73.7 1.38 58.0
Philippines 41.1 0.29 22.3
Portugal 68.0 1.00 50.0
Qatar 57.8 0.62 38.3
Singapore 56.7 0.55 35.7
Thailand 42.5 0.28 21.6
United States
of America
74.0 1.49 59.8
the odds of going abroad for medical care for individuals with
high incomes are lower than the odds for those with average
income by a 70%. Thirdly, the more educated an individual
is, the less likely they are to decide to opt to receive medical
treatment abroad. The odds of travel abroad for medical purposes
for people who have only completed secondary school were
1.73 times higher than the odds for individuals with a Master
or PhD or equivalent. Following the inverse relationship found
to exist between education and medical traveling, the odds of
agreeing to travel for care for individuals who completed their
bachelor degree or equivalent were a 56% lower than the odds for
individuals with a Master’s degree, PhD, or equivalent.
Another important predictor of how likely an individual
would be to decide to opt for medical travel is whether that
individual has previously lived abroad. The odds of traveling for
people living abroad for a time between 6 months and 1 year
are 3.57 times higher than the odds of going abroad for medical
purposes in individuals who spent less than 6 months abroad.
Furthermore, the odds of deciding for medical travel for someone
who has lived abroad more than 1 year are 6.18 times the odds of
deciding for medical travel for someone who has not lived at least
6 months outside his/her home country.
Individual’s perception of their own country’s healthcare
system was expected to be another important factor underlying
their decision to undergo a medical procedure abroad. Again,
the rating of the quality of the quality of the healthcare system
is the most influential factor, as the odds for going abroad for
medical care are decreased by 36% for each one-point increase
of the quality rating. Furthermore, the odds of deciding for
medical travel decreased by 25% with each increased point when
evaluating waiting times. Surprisingly, the opposite eﬀect was
found when participants were asked to evaluate the cost of the
healthcare system in their home country, whereby the odds of
traveling increased by 30% for each increased point. While the
eﬀects of the rating of the cost and waiting time of the home
healthcare are significant, they are less important (by means
of the estimated odd ratio comparison) than the evaluation
of the healthcare system’s quality, which played a greater role
than the other aspects of the healthcare in participants’ home
countries.
Lastly, previous medical travel experience was found to be
negatively related with the decision to travel abroad for care, as
the odds of an individual with previous experience are only 0.61
times the odds of deciding to travel for individuals without any
previous medical travel experiences.
Regarding the comparison with the single-level model, BIC
results indicated that the final multilevel model fits the data better
than the single-level model. Given the known problems of both
the likelihood-ratio test and AIC (Richards, 2005; Bolker, 2008),
it is advised to proceed with caution when interpreting them.
Both techniques have been shown to be extremely conservative
when comparing linear mixed eﬀects models, but no information
regarding their behavior in generalized linear mixed models
was found. In order to provide as many insightful results as
possible, likelihood-ratio test and AIC were presented. Estimates
for fixed eﬀects for the single-level model were expected to be
similar to those found in the final multilevel model condition
that could occur when comparing models with highly balanced
structures. In this case, the randomness of the given country
when providing the test to the participants generated a structure
where the number of observations per country was similar (M =
2.61, min 249, max 268). Estimated standard errors were smaller
for the single-level model than for the final multilevel model.
The diﬀerences between the standard errors of both models is
due to the failure for the single-model to take into account
the non-independence of the observations. The inclusion of
the random term in the final multilevel model lead to less
biased estimation (Bolker, 2008). Therefore, both empirical and
theoretical considerations support the use of the final multilevel
model.
Case Study Discussion
The multilevel approach previously presented is not only
important for providing a correct estimation of the fixed
parameters, but also for providing estimates of random eﬀects
of country of destination (Table 5). These results allow us to
map trends on the medical travel market, whereby participants
are more likely to agree to travel to north European countries
(Germany and United Kingdom) and the USA for medical
care. Australia and New Zealand complete the map of the most
compelling countries when deciding to seek medical attention
abroad. Southern Europe (Portugal and Malta) are less preferred
destination for receivingmedical care. On the other hand,Middle
East (Dubai and Qatar) are not deemed as compelling options.
Lastly, individuals tend to choose not to travel to countries in
Southern-Asia (Thailand, Philippines and Singapore) for medical
purposes.
This case study outlines some of the advantages of the
multilevel method. Firstly, multilevel modeling can generate
unbiased parameter estimates for the fixed eﬀects when a
hierarchical structure are present in the data. In addition to
random eﬀect estimation, multilevel models can also measure the
variance that is explained by those random terms by means of the
Frontiers in Psychology | www.frontiersin.org 9 May 2016 | Volume 7 | Article 752
Garcia-Garzon et al. Multilevel Modeling and Policy Development
ICC, becoming an indicator of the importance of those random
eﬀects. Lastly, multilevel modeling critically improves upon the
classical statistical techniques by increasing the inferential power
of the analysis and by taking into account the eﬀects of higher-
level variables that arise due to the nested structure of the data.
A direct comparison between the multilevel model mentioned
above and a single-level model illustrates how the inclusion of
random eﬀect terms can improve the model fit and lead to less
biased estimates.
Direct comparison with other tools (i.e., the LPC) is diﬃcult
and controversial, as the DCM estimation techniques diﬀer
radically from those employed in multilevel methods. Several
challenges arise when attempting such a direct comparison.
Firstly, neither background theories supporting our study or
DCM studies (that usually encompass utility theory), nor
the data collection methods are relatable, hence allowing
for only speculative conclusions from these comparisons.
Ignoring such caveats would lead to the situation of comparing
results from statistical methods commonly derived from
the generalized linear family and regression analysis, in a
situation where those results could not be directly comparable
without a common theoretical framework (that to our notice,
not psychologist, not econometricians have developed yet).
Nevertheless, as both classes of studies are based on statistical
methods from the generalized linear family, the aforementioned
benefits of using multilevel regression methods apply to both
types of studies, and the presented recommendations could
be also extended to those studies. Even without a direct
comparison of these methods, it is possible to point out
the advantages of multilevel models over DCM methods
and their usefulness to various types of medical travel
data.
Lastly, several limitations could also be identified in the
dataset analyzed here. Above we only presented the case for
the random-intercept model. It includes the assumption that
every first level eﬀect is fixed to be constant across all the
second level units, but this assumption might not hold in
real-world datasets. Therefore, researchers should be aware
that complex models (e.g., random-slopes, random-intercept
and random-slopes, multilevel with cross-levels eﬀects) could
represent alternatives that are more realistic. Sadly, the inclusion
of new random eﬀects comes with the price that more second
level units should be incorporated in the model and that larger
samples are needed.
In addition, 90% of the participants were from European
countries, which reduces the generalizability of our findings to
populations outside Europe regardless of the statistical technique
used. Further discussion of this dataset and its limitations can be
found in Zhukovsky et al. (2015).
DISCUSSION
Implication for Medical Travel Data
Analysis
The motivation behind this article was to demonstrate a new
method not only for the study of the decision-making processes
in medical travel, but also the exploration of existing trade-oﬀs
involved in that decision, aiming to improve the quality of the
research methods in the field relevant to health policy.
A new questionnaire has been theoretically implemented
along with a complementary analytical method. Both are
the result of the application of widely used techniques in
other research areas (i.e., CA/DCM studies) to psychology
and public health. This approach aimed to transfer these
methodologies to our field of interest to improve the quality
of the generated evidence. We argue that multilevel analyses
provide richer inferences due to its greater power, hence
generate more insightful evidence that can be used by
policymakers to adjust their interventions. In addition,
the multilevel approach helps elucidate the complex
relationships between the studied moderators and a certain
set of countries of destination. The eﬀect of a destination
country on the eﬀects of the other variables on the decision-
making process can now be individually analyzed. This goes
significantly beyond what can be inferred from theoretical,
artificial destinations or care options for direct use in
application.
As illustrated by the case study, the application of multilevel
modeling can provide reliable estimation of the coeﬃcients for
various variables, providing trustworthy information about how
the diﬀerent procedures and reasons interact to enhance or
discourage individual’s decision of going abroad due to medical
reasons. Moreover, the eﬀect of demographic factors (i.e., gender,
education, or income) allows the development of medical traveler
profiles.
Multilevel methods are increasingly common in social science
data analysis due to their flexibility for assessing relationships
among diﬀerent units of analysis and their moderators, but
have so far been rather scarce in policy research (Cascio and
Aguinis, 2008). In the future, more widespread application of
these more complicated, yet more sensitive models could serve
to increase the reliability and power of public health policy
research studies. In addition, identifying country-specific trends
and patterns could help international agencies provide most
relevant information to patients and national governments.
As researchers, our ultimate objective is to provide
trustworthy information to governmental agencies, stakeholders
and patients, leading to the generation of evidence-based
policies. New methodologies should be implemented for and
by researchers to be able to analyze complex relationships
and moderated eﬀects in both psychology and public
health areas. Medical traveling is becoming a global and
significant phenomenon, with important economic and social
consequences. Its growing importance is reflected in the
increasing number of publications in this area. Investing time
and eﬀort in developing new research designs would only revert
on social gains, as the quality of the implemented policies grow.
Consequently, the personal benefits of the implementation of
these policies for clients and users would lastly be fostered.
Lastly, the research presented was intended to illuminate the
benefits and the caveats of the application of multilevel modeling
to medical travel phenomena. Four main conclusions may be
drawn from this study:
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1. There is a soundly theoretical ground for justifying the
implementation of multilevel modeling in medical traveling.
When studying social phenomena involving hierarchical
structures with several units (i.e., diﬀerent procedures,
diﬀerent countries, diﬀerent traveling patterns), research
should seek for applying the appropriate statistical methods
(i.e., multilevel modeled).
2. The use of multilevel modeling does not only provide more
accurate information of each of the second-level units (e.g.,
each of the countries), but is also able to disclose the complex
relationships between the unit of the model and the predictors
of the model. Therefore, specific and unique information
can be obtained by using multilevel modeling (e.g., variance
explained by the random eﬀects), which is not accessible in an
accurate fashion by means of using traditional techniques.
3. This information can be directly extrapolated to national
agencies and shareholders, and could have a direct impact
on the decision-making processes and policy development.
Multilevel models do not only provide a more realistic
representation of the medical travel, but encompasses the
analysis of medical travel data into a well-known statistical
framework.
4. When applied to empirical data, the use of multilevel
model allowed an unbiased estimation of the random
and the fixed eﬀects and their standard deviations, being
superior to its single-level counterpart (see Appendix A in
Supplementary Material). Results confirmed that individuals
are more likely to travel to countries in Northern Europe
(England and Germany) and less likely to go to Southern-Asia
countries. Regarding which factors drive the decision-making
processes in medical traveling, treatment’s quality was the
most compelling factor. When individuals faced non-invasive
procedures (i.e., hip replacement), the treatments’ costs were
considered as prominent as the waiting lists. Contrarily,
when individuals confronted life-threating procedures (i.e.,
heart valve replacement), the waiting time was seen as more
influential factor than the treatments’ cost. In addition,
individuals with lower SES, who had lived abroad for more
than 1 year, with no previous medical traveling experience and
with negative views of the quality, cost and waiting times from
their own healthcare system were more likely to travel abroad
for medical care.
Further Developments
The development of strong theoretical approaches is a priority
for gathering scientific knowledge, but it needs to be confirmed
with real data in medical travel. This study introduced a new
data collection method, highlighting its strengths and limitations
and criticized the lack of appropriate statistical techniques in the
field of health policy. Instead, we propose and defend multilevel
modeling as a promising way of detecting eﬀects that so far
have been overlooked due to the inadequacy of traditional DCM
methods. The finding that estimated probabilities of agreeing to
travel to a given country diﬀer from descriptive evidence provides
sound evidence of the importance of the fixed eﬀects in the data.
Multilevel methods are an excellent method of exploring these
eﬀects since they oﬀer greater power to detect small and possibly
interactive eﬀects that may be driven by higher-level units such
as destination country, at the same time relaxing the assumption
of non-independence.
In addition, the sample of participants and/or countries
involved should also be representative of the population under
study and specific to the research question. Studies targeting
diﬀerent populations and diﬀerent travel trends could be carried
out under the proposed method with small modifications.
Nevertheless, 90% of the analyzed sample was formed by
individuals from European countries. Having such a high
percentage of the sample located in a “single” world region could
be stated as a limitation in both the original and this case study.
The proposed method is just an approximation to the
rich world of multilevel analysis. Further developments should
include a generalization of this method using other complex
multilevel architectures. Moreover, random slope, or a random
intercept and random slope model—considering the inclusion of
cross-levels interactions—should be analyzed in future research.
These new models could be implemented to generate new
evidence in the field of medical travel. Particularly interesting
would be the development of models with cross-levels eﬀects
including procedures, reasons, countries of destination and home
country of the participants, in order to properly identify trends
in medical travel, mapping the current medical markets and their
evolution. Presenting an example of the previously theoretically
developed approach, it is expected that researchers on the field
would feel encouraged to explore not only the aforementioned
alternatives, but to incorporate the study of multilevel models in
their own research.
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